Transcriptional Repression from the c-myc P2 Promoter by the Zinc Finger Protein ZF87/MAZ*

ZF87/MAZ is a zinc finger-containing transcription factor that was cloned based on its ability to bind to a site within the c-myc P2 promoter. However, its role in the control of c-myc transcription has not yet been well established. Here we have analyzed the effect of ZF87/MAZ overexpression on transcription from the murine c-myc P2 promoter. It was found that when overexpressed in COS cells, ZF87/MAZ significantly represses transcription from P2. The repression is mediated through the ME1a2 element, located at position −86 relative to the P2 transcriptional start site, and is not mediated through either the E2F or the ME1a1 sites. ZF87/MAZ functions as a true transcriptional repressor since it can repress transcription independently of the c-myc promoter, as part of a fusion with the GAL4 protein. The repressive domain within ZF87/MAZ is located in the amino-terminal half of the protein, a region rich in proline and alanine residues. ZF87/MAZ therefore shares features (i.e.a Pro/Ala-rich region) with those of known transcriptional repressor proteins.

[1]  G. Evan,et al.  A matter of life and cell death. , 1998, Science.

[2]  M. Bjornsti,et al.  Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I* , 1998, The Journal of Biological Chemistry.

[3]  T. Shenk,et al.  Activation of the adenovirus major late promoter by transcription factors MAZ and Sp1 , 1997, Journal of virology.

[4]  Y. Shi,et al.  Multiple mechanisms of transcriptional repression by YY1 , 1997, Molecular and cellular biology.

[5]  K. Calame,et al.  Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. , 1997, Science.

[6]  K. Calame,et al.  Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. , 1997, Genes & development.

[7]  K. Itakura,et al.  Binding of THZif-1, a MAZ-like Zinc Finger Protein to the Nuclease-hypersensitive Element in the Promoter Region of the c-MYC Protooncogene* , 1996, The Journal of Biological Chemistry.

[8]  K. Itakura,et al.  Members of the MAZ family: a novel cDNA clone for MAZ from human pancreatic islet cells. , 1996, Biochemical and biophysical research communications.

[9]  M. Komatsu,et al.  Specific regulation of gene expression by antisense nucleic acids: a summary of methodologies and associated problems. , 1996, Artificial organs.

[10]  P. Neiman,et al.  An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes , 1996, Molecular and cellular biology.

[11]  Shiaw-Yih Lin,et al.  Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction , 1996, Molecular and cellular biology.

[12]  Thomas Shenk,et al.  The Serotonin 1a Receptor Gene Contains a TATA-less Promoter that Responds to MAZ and Sp1 (*) , 1996, The Journal of Biological Chemistry.

[13]  A. Patel,et al.  v-Abl activates c-myc transcription through the E2F site , 1995, Molecular and cellular biology.

[14]  S. Hedrick,et al.  A Myc-associated zinc finger protein binding site is one of four important functional regions in the CD4 promoter , 1995, Molecular and cellular biology.

[15]  E. Moran,et al.  Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. , 1995, Genes & development.

[16]  A. Patel,et al.  MAZ‐dependent termination between closely spaced human complement genes. , 1994, The EMBO journal.

[17]  D. Dufort,et al.  The human cut homeodomain protein represses transcription from the c-myc promoter , 1994, Molecular and cellular biology.

[18]  D. Levens,et al.  A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. , 1994, Genes & development.

[19]  S. Rusconi,et al.  Transcriptional activation modulated by homopolymeric glutamine and proline stretches. , 1994, Science.

[20]  F. A. La Rosa,et al.  Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors , 1994, Molecular and cellular biology.

[21]  K. Calame,et al.  Yin-yang 1 activates the c-myc promoter , 1993, Molecular and cellular biology.

[22]  D. Hall,et al.  Physical characteristics of a factor related to the c-myc/insulin promoter binding protein ZF87/Pur-1. , 1993, Biochemical and biophysical research communications.

[23]  J. Manley,et al.  Transcriptional repression by the Drosophila even-skipped protein: definition of a minimal repression domain. , 1993, Genes & development.

[24]  W. Rutter,et al.  Characterization of a cDNA encoding the insulin gene GAGA-binding factor, Pur-I. , 1993, Biochemical Society transactions.

[25]  W. Rutter,et al.  Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Patel,et al.  MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Moberg,et al.  Wild‐type murine p53 represses transcription from the murine c‐myc promoter in a human glial cell line , 1992, Journal of cellular biochemistry.

[28]  K. Moberg,et al.  Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoter. , 1992, Biochemistry.

[29]  K. Moberg,et al.  Three distinct elements within the murine c-myc promoter are required for transcription. , 1992, Oncogene.

[30]  Yang Shi,et al.  Transcriptional repression by YY1, a human GLI-Krüippel-related protein, and relief of repression by adenovirus E1A protein , 1991, Cell.

[31]  K. Moberg,et al.  Analysis of the c‐myc P2 promoter , 1991, Journal of cellular physiology.

[32]  J. Martial,et al.  The evolutionarily conserved Krüppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Calame,et al.  Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal alpha-actin promoter, and the immunoglobulin heavy-chain enhancer , 1991, Molecular and cellular biology.

[34]  B. Strober,et al.  A far upstream element stimulates c-myc expression in undifferentiated leukemia cells. , 1990, The Journal of biological chemistry.

[35]  J. Nevins,et al.  A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. , 1990, The EMBO journal.

[36]  C. Asselin,et al.  A cis-acting element in the promoter region of the murine c-myc gene is necessary for transcriptional block , 1989, Molecular and cellular biology.

[37]  E. A. O'neill,et al.  The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain , 1989, Cell.

[38]  R. Weinberg,et al.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.

[39]  L. Staudt,et al.  fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. , 1989, The Journal of biological chemistry.

[40]  C. Asselin,et al.  Molecular requirements for transcriptional initiation of the murine c-myc gene. , 1989, Oncogene.

[41]  M Lipp,et al.  E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M Lipp,et al.  Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. , 1989, Genes & development.

[43]  N. Hay,et al.  A FOS protein is present in a complex that binds a negative regulator of MYC. , 1989, Genes & development.

[44]  A. Boulton,et al.  Effect of L-Dopa Therapy on Urinary p-Tyramine Excretion and EEG Changes in Parkinson's Disease , 1972, Nature.

[45]  M. Potter,et al.  The c-myc story: where we've been, where we seem to be going. , 1997, Current topics in microbiology and immunology.

[46]  A. Patel,et al.  Differential regulation of the c-MYC P1 and P2 promoters in the absence of functional tumor suppressors: implications for mechanisms of deregulated MYC transcription. , 1997, Current topics in microbiology and immunology.

[47]  A. Patel,et al.  myc function and regulation. , 1992, Annual review of biochemistry.

[48]  M. Groudine,et al.  Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.

[49]  Hall Dj.  Regulation of c-myc transcription in vitro: dependence on the guanine-rich promoter element ME1a1. , 1990 .

[50]  M. Cole.  The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.